The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Contract Win and Trading Update

30 Nov 2020 07:00

RNS Number : 8380G
Location Sciences Group PLC
30 November 2020
 

30 November 2020

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

New Contract Win, Trading Update and Change of Registered Office

 

Location Sciences (AIM: LSAI), the leading location verification company, is pleased to announce it has signed its second customer, The Spoken Thought, Inc., to its GeoProtect (Verify Audience) platform.

 

The Spoken Thought, Inc. (trading as Mira) is a high value audience segment supplier to leading brands and media agencies across the US. It will use the Location Sciences GeoProtect platform to independently verify audience segments in order to offer its customers a visibly differentiated premium product compared to its competitors.

 

The quality of the data used to build audience segments matters to brands and agencies and can dramatically impact the performance of their advertising campaigns. In today's data marketplace, however, it is virtually impossible for brands and agencies to distinguish between good and bad quality audience data. Consequently, Location Sciences' third-party independent certification is an excellent tool for suppliers of audience segments to clearly and visibly demonstrate the quality of their products in this crowded data marketplace.

 

Location Sciences and Mira have been developing their partnership throughout 2020 and the signing of this agreement crystalises an enormous amount of hard work by both parties. The partnership being entered into now should enable Mira to deliver more accurate high value audience segments to its customers.

 

Whilst revenues under this agreement are expected to begin to accrue to Location Sciences during the remainder of 2020, the main revenue benefit should become evident in 2021 and beyond.

Mark Slade, CEO, Location Sciences, commented: "Mira's decision to join a growing set of US suppliers in offering complete transparency to their customers is a testament to their business and commitment to high-quality products. This win builds on excellent work already underway with other suppliers, who are leveraging our partnership to win new business."

 

Jon Frangakis, CEO, Mira, added: "Working with Location Sciences gives us the platform to show our customers the true quality and accuracy of our audiences. We have been impressed with the GeoProtect platform and the Location Sciences team, and we look forward to progressing our partnership in 2021."

 

Trading Update

 

Throughout 2020, Verify revenues have been adversely impacted by significantly reduced advertising spend as a result of Covid-19, and the UK's second nationwide lockdown in November could not have come at a worse time for the business. Consequently, the anticipated pick up in Verify revenues in Q4 2020 (typically the busiest quarter for location-based advertising) has not materialised and therefore Verify revenues will be lower than the Company's expectations.

 

The directors remain confident in the market opportunity for Verify and expect revenues to increase from existing customers as well as new client wins as location-based advertising returns during the first half of 2021.

 

The reduced revenue from Verify has been partly offset with additional revenues secured from Location Science's Insights products, with new client wins for the Company's market leading geo-mobility insights, including securing a partnership with the NHS to help its efforts in fighting the transmission of Covid-19.

 

Supporting the NHS

 

Location Sciences data insights products continue to help to inform the ongoing response to Covid-19. Through its long-term partnership with CACI, Location Sciences is supplying data to support NHS England and members of the Scientific Pandemic Influenza Group on Modelling (SPI-M) in their analysis of how movement of individuals is impacting the reproduction number (R) and growth rate of Covid-19 in the UK.

 

Location Sciences is pleased to be supporting NHS England - helping it to understand how people are moving around and exploring how this may impact the spread of the Covid-19 virus.

 

Cash Resources Sufficient until 2022

 

As part of its ongoing efforts to mitigate the impact of Covid-19, the board has and is taking further measures to reduce the Company's overheads and seek operational efficiencies where possible. These actions include moving to remote working in London and the US and rationalising the Company's new business generation operations in the US. These actions will lead to the Company having reduced cash requirements such that the board now believes the Company has sufficient cash reserves until early 2022. As at 30 November 2020, the Company had cash of approximately £1.2 million.

 

Mark Slade, CEO, Location Sciences, comments: "The new partnerships developed in 2020 - in challenging circumstances - are incredibly encouraging. It's pleasing to see high-quality location data being valued by the advertising industry and beyond, as public sector bodies realise the impact of movement on society. As we move towards a new year, we are optimistic that we will continue this momentum."

 

Change of Registered Office

 

With effect from 1 December 2020, the Company's registered office will be moved to the Company's company secretarial offices at First Floor, St James House, St James Square, Cheltenham, Gloucestershire GL50 3PR.

 

A further update on trading and prospects is expected to be provided in late January 2021.

 

 

For further information please contact:

 

Location Sciences Group PLC

via Milk & Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, CFO and Commercial Director

 

 

 

Allenby Capital Limited (Nominated Adviser)

Tel: +44 (0)20 3328 5656

David Hart

James Hornigold

 

 

 

Peterhouse Capital (Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

Milk & Honey PR

Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

 

About Location Sciences Group PLC:

 

Location Sciences is the pre-eminent global location verification provider to the $160 billion digital advertising industry. Working in partnership with brands, media agencies and suppliers to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns.

 

The digital advertising market-place remains unregulated and un-monitored, with an estimated $19 billion wasted on ad-fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad-fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

 

Rule 26 website: www.locationsciencesgroup.ai

Verify website: www.locationsciences.ai

LinkedIn: https://www.linkedin.com/company/locationsciences

Twitter: @LocationSci

 

About Mira

 

Mira (also known as The Spoken Thought) are a high value audience segment supplier to leading brands and media agencies across the US. In addition, Mira designs, builds, and operates data sets that make Out of Home media function more like digital media via its crowd analytics platform. Mira was founded in 2015 by two brothers, Jonathan and Gabe Frangakis and is based in New York, NY and Durham, NC.

 

Website: https://mira.co/

LinkedIn: https://www.linkedin.com/company/the-spoken-thought/

Twitter: @Mira_Analytics

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKCBNOBDDODB
Date   Source Headline
18th Sep 20177:00 amRNSHalf-year Report and Trading Update
14th Sep 20176:03 pmRNSTR-1: Notification of major holdings
13th Sep 201712:40 pmRNSTR-1: Notification of major holdings
11th Sep 20177:00 amRNSLaunch of Location Sciences
6th Sep 20174:59 pmRNSTR-1: Notification of major holdings
5th Sep 20172:49 pmRNSTR-1: Notification of major holdings
29th Aug 20177:00 amRNSNew Directorship
25th Aug 20171:31 pmRNSTR-1: Notification of major holdings
24th Aug 20171:17 pmRNSTR-1: Notification of major holdings
10th Aug 20177:00 amRNSSettlement of credit facility and loan note
9th Aug 20173:00 pmRNSTR-1: Notification of major holdings
28th Jul 20173:43 pmRNSTR-1: Notification of major holdings
27th Jul 20174:04 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
24th Jul 201711:54 amRNSResult of AGM and GM
24th Jul 20177:01 amRNSAGM Statement
24th Jul 20177:00 amRNSResult of Open Offer
17th Jul 20177:00 amRNSProxama signs agreement with Rail Delivery Group
13th Jul 20177:00 amRNSContract Renewal
3rd Jul 20176:01 pmRNSHolding(s) in Company
30th Jun 201711:31 amRNSResult of Placing
30th Jun 20177:01 amRNSProposed Placing
30th Jun 20177:00 amRNSFinal Results
25th May 20177:00 amRNSNew Contracts
18th May 20177:00 amRNSBoard Changes
17th May 20177:00 amRNSConclusion of the Strategic Review
27th Apr 20171:07 pmRNSNotification of Interest In Shares
28th Mar 20172:04 pmRNSIssue of Equity and Total Voting Rights
7th Mar 20177:00 amRNSDirector Declaration
1st Mar 20174:39 pmRNSResult of General Meeting
1st Mar 20177:00 amRNSNew Contract Win
16th Feb 20177:00 amRNSAppointment of Non-Executive Chairman
13th Feb 20177:00 amRNSPosting of Circular and Notice of General Meeting
9th Feb 20173:40 pmRNSHolding(s) in Company
6th Feb 20177:00 amRNSNew Contract Win
3rd Feb 20177:00 amRNSIssue of Equity
23rd Jan 20177:00 amRNSNew Partnership
10th Jan 20177:00 amRNSBeacon network expansion
5th Jan 201710:20 amRNSTotal Voting Rights
3rd Jan 20178:00 amRNSBlock listing
21st Dec 20167:00 amRNSNew Contract
13th Dec 20167:00 amRNSTrading and Funding update
25th Nov 20167:00 amRNS'Santa Forgot' campaign for Alzheimer's Research
29th Sep 20167:00 amRNSHalf-year Report
23rd Sep 20162:55 pmRNSHolding(s) in Company
22nd Sep 20165:22 pmRNSExercise of Options
22nd Sep 20167:00 amRNSNew Contract
2nd Sep 20167:00 amRNSGoogle Certification
11th Aug 20163:24 pmRNSTR-1 Notification of Major Interest in Shares
11th Aug 20163:20 pmRNSDirector/PDMR Shareholding
27th Jul 20164:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.